Literature DB >> 22914817

High incidence and prevalence of systemic lupus erythematosus in Norway.

K Lerang1, I Gilboe, T Garen, D S Thelle, J T Gran.   

Abstract

Our aim was to identify all patients with systemic lupus erythematosus (SLE) within the city of Oslo from 1999-2008 and to estimate the incidence and prevalence of SLE according to age, sex and ethnicity. Adults (16 years and over) with SLE were identified from five different sources. Only patients fulfilling four or more of the updated 1997 American College of Rheumatology (ACR) criteria were included. The incidence was stable during the nine year study period, with a mean annual incidence rate of 3.0 per 100,000 at risk (95% confidence interval (CI) 2.4-3.5). Females exhibited a bimodal pattern in age specific incidence with the first peak at 16-29 years of age and the second at 50-59 years of age. The overall prevalence was 51.8 per 100,000 population (95% CI 45.2-58.4), with 91.0 (95% CI 78.8-103.1) for females and 10.7 (95% CI 6.4-15.0) for males. The prevalence proportions for European descendants were similar to those for Asians but statistically significant lower than those for individuals adopted from non-European countries. The findings indicate a higher prevalence in Norwegians compared to Caucasians in Denmark and England. The higher prevalence of SLE in foreign adopted individuals warrants further examination.

Entities:  

Mesh:

Year:  2012        PMID: 22914817     DOI: 10.1177/0961203312458168

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  12 in total

1.  Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States.

Authors:  Sudumpai Jarukitsopa; Deana D Hoganson; Cynthia S Crowson; Olayemi Sokumbi; Mark D Davis; Clement J Michet; Eric L Matteson; Hilal Maradit Kremers; Vaidehi R Chowdhary
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

Review 2.  Prevalence of Skin and Skin-Related Diseases in the Rochester Epidemiology Project and a Comparison with Other Published Prevalence Studies.

Authors:  Louise K Andersen; Mark D P Davis
Journal:  Dermatology       Date:  2016-03-25       Impact factor: 5.366

Review 3.  Diagnostic criteria for systemic lupus erythematosus: has the time come?

Authors:  George K Bertsias; Cristina Pamfil; Antonios Fanouriakis; Dimitrios T Boumpas
Journal:  Nat Rev Rheumatol       Date:  2013-07-09       Impact factor: 20.543

4.  Concomitant systemic lupus erythematosus might have a negative impact on the biochemical responses to treatment in patients with primary biliary cholangitis.

Authors:  Xiaoli Fan; Ruoting Men; Ping Ni; Changli Lu; Tengfei Si; Yun Ma; Li Yang
Journal:  Clin Rheumatol       Date:  2019-12-06       Impact factor: 2.980

Review 5.  The global burden of SLE: prevalence, health disparities and socioeconomic impact.

Authors:  Erin E Carter; Susan G Barr; Ann E Clarke
Journal:  Nat Rev Rheumatol       Date:  2016-08-25       Impact factor: 20.543

6.  Prevalence and incidence of systemic lupus erythematosus in South Korea.

Authors:  Jee-Seon Shim; Yoon-Kyoung Sung; Young Bin Joo; Hye-Soon Lee; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

Review 7.  Incidence of diseases primarily affecting the skin by age group: population-based epidemiologic study in Olmsted County, Minnesota, and comparison with age-specific incidence rates worldwide.

Authors:  Laurel L Wessman; Louise K Andersen; Mark D P Davis
Journal:  Int J Dermatol       Date:  2018-01-29       Impact factor: 2.736

8.  The incidence and prevalence of systemic lupus erythematosus in the UK, 1999-2012.

Authors:  Frances Rees; Michael Doherty; Matthew Grainge; Graham Davenport; Peter Lanyon; Weiya Zhang
Journal:  Ann Rheum Dis       Date:  2014-09-29       Impact factor: 19.103

9.  Trend of prevalence and incidence of systemic lupus erythematosus in South Korea, 2005 to 2015: a nationwide population-based study.

Authors:  Eun Hui Bae; Sang Yeob Lim; Kyung-Do Han; Jin-Hyung Jung; Hong Sang Choi; Ha Yeon Kim; Chang Seong Kim; Seong Kwon Ma; Soo Wan Kim
Journal:  Korean J Intern Med       Date:  2019-06-21       Impact factor: 2.884

10.  Interleukin-6 receptor alpha blockade improves skin lesions in a murine model of systemic lupus erythematosus.

Authors:  Peter Birner; Susanne Heider; Peter Petzelbauer; Peter Wolf; Christoph Kornauth; Madeleine Kuroll; Olaf Merkel; Günter Steiner; Tadamitsu Kishimoto; Stefan Rose-John; Afschin Soleiman; Richard Moriggl; Lukas Kenner
Journal:  Exp Dermatol       Date:  2016-02-13       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.